Next Article in Journal
Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover
Previous Article in Journal
PTEN Protein Loss and Loss-of-Function Mutations in Gastric Cancers: The Relationship with Microsatellite Instability, EBV, HER2, and PD-L1 Expression
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 12
Issue 7
10.3390/cancers12071728
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Erratum to Cancers 2020, 12(3), 713.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713

by
Marc Castellví
1,2,†,
Eudald Felip
2,3,†,
Ifeanyi Jude Ezeonwumelu
1,2,
Roger Badia
1,2,
Edurne Garcia-Vidal
1,2,
Maria Pujantell
1,2,
Lucía Gutiérrez-Chamorro
1,2,
Iris Teruel
2,3,
Anna Martínez-Cardús
2,3,
Bonaventura Clotet
1,2,
Eva Riveira-Muñoz
1,2,
Mireia Margelí
2,3,
José A. Esté
1,4 and
Ester Ballana
1,2,*
1
IrsiCaixa AIDS Research Institute, Badalona, 08916 Catalonia, Spain
2
Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain
3
Institut Català d’Oncologia, Badalona, 08916 Catalonia, Spain
4
Cienciatraducida, 08391 Barcelona, Spain
*
Author to whom correspondence should be addressed.
†
Theses authors contributed equally this work.
Cancers 2020, 12(7), 1728; https://doi.org/10.3390/cancers12071728
Submission received: 5 June 2020 / Accepted: 8 June 2020 / Published: 29 June 2020
Versions Notes
The authors wish you make the following corrections to this paper [1].
One contributor’s name was missing in the original version of the authorship. The original version of the authorship is:
Marc Castellví 1,2,†, Eudald Felip 2,3,†, Ifeanyi Jude Ezeonwumelu 1,2, Roger Badia 1,2, Edurne Garcia-Vidal 1,2, Maria Pujantell 1,2, Lucía Gutiérrez-Chamorro 1,2, Iris Teruel 2,3, Anna Martínez-Cardús 2,3, Bonaventura Clotet 1,2, Eva Riveira-Muñoz 1,2, Mireia Margelí 2,3 and Ester Ballana 1,2,*
and should be replaced with:
Marc Castellví 1,2,†, Eudald Felip 2,3,†, Ifeanyi Jude Ezeonwumelu 1,2, Roger Badia 1,2, Edurne Garcia-Vidal 1,2, Maria Pujantell 1,2, Lucía Gutiérrez-Chamorro 1,2, Iris Teruel 2,3, Anna Martínez-Cardús 2,3, Bonaventura Clotet 1,2, Eva Riveira-Muñoz 1,2, Mireia Margelí 2,3, José A. Esté 1,4, and Ester Ballana 1,2,*
The updated “Author Contributions” should be

Author Contributions

Conceptualization, J.A.E., E.R.-M., M.M and E.B.; Formal analysis, M.M., J.A.E. and E.B.; Investigation, M.C., E.F., I.J.E, R.B, E.G.-V., M.P. and L.G.-C-; Methodology, I.T. and A.M.-C.; Supervision, B.C. and J.A.E.; Writing – original draft, E.B. and J.A:E.; Writing – review & editing, E.R.-M. and E.B. All authors have read and agreed to the published version of the manuscript

Reference

  1. Castellví, M.; Felip, E.; Ezeonwumelu, I.J.; Badia, R.; Garcia-Vidal, E.; Pujantell, M.; Gutiérrez-Chamorro, L.; Teruel, I.; Martínez-Cardús, A.; Clotet, B.; et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713. [Google Scholar] [CrossRef] [Green Version]

Share and Cite

MDPI and ACS Style

Castellví, M.; Felip, E.; Ezeonwumelu, I.J.; Badia, R.; Garcia-Vidal, E.; Pujantell, M.; Gutiérrez-Chamorro, L.; Teruel, I.; Martínez-Cardús, A.; Clotet, B.; et al. Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713. Cancers 2020, 12, 1728. https://doi.org/10.3390/cancers12071728

AMA Style

Castellví M, Felip E, Ezeonwumelu IJ, Badia R, Garcia-Vidal E, Pujantell M, Gutiérrez-Chamorro L, Teruel I, Martínez-Cardús A, Clotet B, et al. Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713. Cancers. 2020; 12(7):1728. https://doi.org/10.3390/cancers12071728

Chicago/Turabian Style

Castellví, Marc, Eudald Felip, Ifeanyi Jude Ezeonwumelu, Roger Badia, Edurne Garcia-Vidal, Maria Pujantell, Lucía Gutiérrez-Chamorro, Iris Teruel, Anna Martínez-Cardús, Bonaventura Clotet, and et al. 2020. "Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713" Cancers 12, no. 7: 1728. https://doi.org/10.3390/cancers12071728

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop